双基酶USP9X调节RIT1蛋白的丰富性和瘤性表型
Amanda K Riley1,2, Michael Grant3, Aidan Snell3
1Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
iScience
|August 20, 2024
概括
双基因酶USP9X调节肺癌中的RIT1蛋白水平. 抑制USP9X降低了RIT1的丰度,使癌细胞对EGFR氨酸激酶抑制剂重新敏感.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- RIT1是肺癌中尚未研究的瘤基因,结构上与RAS GTPases相似.
- 目前还不完全了解RIT1活动的调节,但蛋白质丰富度至关重要.
- 此前USP9X已被确定为RIT1突变肺癌细胞的依赖性.
研究的目的:
- 调查USP9X和RIT1.1之间的监管关系.
- 为了确定USP9X二维基因酶活性是否影响RIT1蛋白的稳定性和丰度.
- 评估针对RIT1驱动肺癌USP9X的治疗潜力.
主要方法:
- 已证明RIT1是USP9X的基质,适用于野生类型和突变形式.
- 利用USP9X枯竭来评估对RIT1蛋白稳定性和丰度的影响.
- 评估了USP9X枯竭对EGFR氨酸激酶抑制剂的敏感性的影响,在体外和体内.
主要成果:
- USP9X二维基因酶活性对于保持RIT1蛋白的稳定性和丰富性至关重要.
- 耗尽USP9X显著降低了RIT1蛋白水平.
- 抑制USP9X会使RIT1驱动的肺癌细胞对EGFR氨酸激酶抑制剂重新敏感.
结论:
- USP9X是RIT1蛋白丰富性和稳定性的关键调节者.
- 针对USP9X代表了RIT1驱动的肺癌的潜在治疗策略.
- 这项研究扩大了对肺癌中RIT1瘤基因调节的理解.
更多相关视频
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
The Proteasome
819
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
819


